logo
Select company
Select metric
8.06%Net Margin
VS
Market
64
Sector
83
Industry
87
History
100
$ 13.83Close
$ 9.55 - $ 70 52-Week Range
Ticker Information

Ticker

KROS

Company Name

KEROS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KEROS THERAPEUTICS INC - Net Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KROS - Net % Historical data
DateNet Income Common StockNet MarginRevenues
6/30/2025$ 18.77M8.06%$ 232.84M
3/31/2025$ 4.21M1.96%$ 214.71M
12/31/2024$ -187.35M-5277.55%$ 3.55M
9/30/2024$ -181.57M-27890.94%$ 651K
6/30/2024$ -168.05M-62012.55%$ 271K
3/31/2024$ -160.3M-68505.13%$ 234K
12/31/2023$ -152.99M-101319.21%$ 151K
9/30/2023$ -142.47M-1780837.5%$ 8K
6/30/2023$ -126.54M0%$ 0
3/31/2023$ -116.3M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) Net % stands at 0%.
  • Over the past 5 years, KEROS THERAPEUTICS INC's average Net % has been -154424.04%.
  • The median Net % for KEROS THERAPEUTICS INC during this period was -16584.24%
  • KEROS THERAPEUTICS INC reached its highest Net % over the past 5 years at 8.06%.
  • The lowest Net % recorded by KEROS THERAPEUTICS INC in the same timeframe -1780837.5%

KEROS THERAPEUTICS INC's Net % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net % Benchmarks
CompanyNet %
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -90.21%DNA : GINKGO BIOWORKS HOLDINGS INC -136.56%DAWN : DAY ONE BIOPHARMACEUTICALS INC -50.63%RIGL : RIGEL PHARMACEUTICALS INC 36.51%STOK : STOKE THERAPEUTICS INC 26.26%XNCR : XENCOR INC -116.44%AKBA : AKEBIA THERAPEUTICS INC -17.91%ANAB : ANAPTYSBIO INC -107.66%RGNX : REGENXBIO INC -112.7%PHAT : PHATHOM PHARMACEUTICALS INC -289.51%

Definition of Net Margin

[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Net Inc. Cmn. / Revenues
(=) Net %
Net % for KEROS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -45.36M ] / Revenues [ $ 0 ]
(=) Net % [ 0% ]

KROS - Net Margin, Last 5 years

-1780837.5%

Minimum

Sep 30, 2023

8.06%

Maximum

Jun 30, 2025

-154424.04%

Average

-16584.24%

Median

Net % Benchmark Analysis

The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
filtered constituents3.2K
min-64.23%
max69.74%
average4.77%
median5.24%
std19.84%